ERBB2 and neoplasm: Further in vivo studies in SK‐BR‐3 tumour‐bearing nude mice reinforced CTPZ8's HER2‐targeting specificity and demonstrated enhanced antiproliferative effects compared with free Camptothecin, while maintaining a favourable biosafety profile [64].